Efavirenz/ Emtricitabine/ Tenofovir Disoproxyl Fumarate Aurobindo

Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Aurobindo is a combination medication used in the treatment of HIV. This oral medication is manufactured by Aurobindo Pharma B.V. and is designed to help manage HIV infection.

Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Aurobindo is primarily used as part of antiretroviral therapy to treat HIV infection. This combination medication works by reducing the amount of HIV in the body, helping to improve immune function and reduce the risk of HIV-related complications. It is often prescribed to adults and adolescents as part of a comprehensive treatment plan.

Common effects of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Aurobindo may include dizziness, nausea, and headache. Some individuals may also experience changes in dream patterns or difficulty sleeping. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

This medication should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Aurobindo should not be taken with certain other medications, and it is crucial to inform your healthcare provider about all medications you are currently taking.

Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Aurobindo may interact with other medications, including those metabolized by the liver's cytochrome P450 system. It is important to avoid alcohol while taking this medication, as it can increase the risk of side effects. Always consult a healthcare provider before starting or stopping any medication while on this treatment.